Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 72 | 119 | 136 | 43 | 68 |
| Gross Profit | 72 | 119 | 136 | 43 | 68 |
| Operating Expenses | 5,514 | 6,616 | 4,499 | 4,145 | 4,192 |
| Operating Income | -5,442 | -6,497 | -4,363 | -4,102 | -4,124 |
| Other Income | 263 | -100 | -134 | -22 | 35 |
| Pre-tax Income | -5,179 | -6,597 | -4,497 | -4,124 | -4,089 |
| Net Income Continuous | -5,179 | -6,597 | -4,497 | -4,124 | -4,089 |
| Net Income | $-5,179 | $-6,597 | $-4,497 | $-4,124 | $-4,089 |
| EPS Basic Total Ops | -0.14 | 0.03 | -0.19 | -0.51 | -0.41 |
| EPS Basic Continuous Ops | -0.14 | -0.04 | -0.19 | -0.28 | -0.41 |
| EPS Diluted Total Ops | -0.14 | 0.03 | -0.19 | -0.51 | -0.41 |
| EPS Diluted Continuous Ops | -0.14 | -0.04 | -0.19 | -0.28 | -0.41 |
| EBITDA(a) | $-5,119 | $-6,380 | $-4,248 | $-3,987 | $-4,005 |